ADC Therapeutics listed its shares on the New York Stock Exchange (ticker symbol ADCT). It is the first Swiss company to go public in 2020.
Redbiotec, a Swiss developer of a therapeutic vaccine for genital herpes, plans to close CHF 9m Series A round this year
Bär & Karrer advised the founders on the salle of a Majority Stake in the zahnarztzentrum.ch Group.
Deborah Sutter has joined Wenger & Vieli as new associate. She works mainly in the areas of inheritance law and estate planning.
The shareholder of Odlo has completed the sale of Swiss-based ODLO International and its subsidiaries to Monte Rosa Sports Holding.
As exclusive Lex Mundi member firm for Switzerland, Pestalozzi has taken part to the report. In particular, partner Christoph Lang and associate Severin Etzensperger provided all the information required.
As reported by the firm, Lenz & Staehelin is advising global telecommunications service provider on regulatory and contract requirements for its M2M and IoT service offerings in Switzerland.
Homburger advised UBS on its issuance of CHF 340,000,000 0.170 per cent. Notes due May 2022 under its Euro Note Programme
The shareholders of Swissbit entered into a share purchase agreement with Ardian regarding the sale of the Swissbit group, an European provider of NAND-flash based storage and embedded Internet of Things (IoT) solutions.
Most respondents (88%) say the DACH (Germany, Austria and Switzerland) economies offer the most deal opportunities within Europe.
